OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164954. A total of 3 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,000 | 0.0% | 1,400 | -26.3% | 0.00% | – |
| Q1 2016 | $1,000 | -96.0% | 1,900 | -86.7% | 0.00% | – |
| Q4 2015 | $25,000 | -97.3% | 14,300 | -96.8% | 0.00% | -100.0% |
| Q3 2015 | $932,000 | -57.0% | 441,800 | +1.0% | 0.01% | -56.7% |
| Q2 2015 | $2,165,000 | -62.4% | 437,400 | -40.6% | 0.03% | -66.7% |
| Q1 2015 | $5,764,000 | +558.7% | 736,200 | +409.8% | 0.09% | +592.3% |
| Q4 2014 | $875,000 | -58.3% | 144,400 | -70.7% | 0.01% | -59.4% |
| Q3 2014 | $2,098,000 | -33.7% | 492,400 | -3.8% | 0.03% | -34.7% |
| Q2 2014 | $3,163,000 | +31.7% | 511,800 | +38.5% | 0.05% | +22.5% |
| Q1 2014 | $2,401,000 | +125.9% | 369,400 | +95.7% | 0.04% | +150.0% |
| Q4 2013 | $1,063,000 | -12.4% | 188,800 | -4.4% | 0.02% | -30.4% |
| Q3 2013 | $1,213,000 | +26.9% | 197,500 | +20.9% | 0.02% | -4.2% |
| Q2 2013 | $956,000 | – | 163,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 163,400 | $956,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 436 | $255,000 | 0.02% |
| Citadel Advisors | 48,400 | $283,000 | 0.00% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 10,000 | $58,000 | 0.00% |